AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Comparison of pregnancy outcomes and vaginal microbiota in women with endometriosis undergoing frozen embryo transfer using letrozole combined with HMG versus hormone replacement therapy with GnRH-a pretreatment

Jie ZhangLei DaiChunyan JiangYuxin ZhaoXiang MaYugui Cui( )Jiayin Liu( )
State Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China
Show Author Information

Abstract

This study investigated differences in reproductive outcomes and vaginal microbiota profiles between two endometrial preparation protocols—letrozole (LE) combined with human menopausal gonadotropin (HMG) and hormone replacement therapy (HRT) with gonadotropin-releasing hormone agonist (GnRH-a) pretreatment—in women with endometriosis undergoing frozen embryo transfer (FET). Following 1∶1 propensity score matching, a total of 770 FET cycles were analyzed. No statistically significant differences were observed in live birth rates or clinical pregnancy rates between the two groups. However, the LE + HMG group showed a nonsignificant trend toward a lower miscarriage rate (13.7% vs. 19.8%, P = 0.070), as well as lower observed rates of cesarean delivery (64.9% vs. 75.4%, P = 0.020) and hypertensive disorders of pregnancy (4.8% vs. 10.1%, P = 0.039). Previous evidence suggests an association between GnRH-a treatment and reproductive tract microbiota composition. Given the clinical and ethical constraints of endometrial sampling during FET, vaginal microbiota was evaluated as a non-invasive indicator of lower reproductive tract microbial composition. In the prospective arm, vaginal samples from 55 women in the LE + HMG group and 50 in the GnRH-a HRT group were analyzed using 16S rRNA sequencing and droplet digital PCR. While no significant differences were observed in Lactobacillus or Gardnerella abundance, the GnRH-a HRT group showed higher relative abundances of several low-abundance taxa, such as Escherichia-Shigella, Limosilactobacillus, and Staphylococcus. In conclusion, although both protocols achieved comparable live birth outcomes, the LE + HMG regimen was associated with lower rates of cesarean delivery and hypertensive disorders of pregnancy, while the two protocols exhibited differences in several low-abundance vaginal bacterial taxa. However, longitudinal studies incorporating baseline and repeated sampling are needed to clarify temporal relationships and causality.

CLC number: R711.71 Document code: A

Electronic Supplementary Material

Download File(s)
JBR-2025-0205_ESM.pdf (3.7 MB)

References

【1】
【1】
 
 
Journal of Biomedical Research
Pages 395-409

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang J, Dai L, Jiang C, et al. Comparison of pregnancy outcomes and vaginal microbiota in women with endometriosis undergoing frozen embryo transfer using letrozole combined with HMG versus hormone replacement therapy with GnRH-a pretreatment. Journal of Biomedical Research, 2026, 40(4): 395-409. https://doi.org/10.7555/JBR.39.20250205

3

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 10 May 2025
Revised: 28 May 2025
Accepted: 03 June 2025
Published: 28 July 2026
© 2026 by Journal of Biomedical Research.

This is an open access article under the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.